about
Sodium current reduction unmasks a structure-dependent substrate for arrhythmogenesis in the normal ventriclesGenetics of Brugada syndromeHyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesThe role of ion channelopathies in sudden cardiac death: implications for clinical practice.Safe single-dose administration of propofol in patients with established Brugada syndrome: a retrospective database analysis.Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome.Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand.p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndromePrevalence of Atrial Fibrillation in Patients with Brugada Syndrome in Taiwan.Inhibition of the cardiac Na⁺ channel Nav1.5 by carbon monoxide.Genetics of Brugada syndrome.Determining the pathogenicity of genetic variants associated with cardiac channelopathies.Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndromeMultiple lithium-dependent Brugada syndrome unmasking events in a bipolar patient.Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man.Cardiac ion channelopathies and the sudden infant death syndromeSudden Unexplained Nocturnal Death Syndrome in Central China (Hubei): A 16-Year Retrospective Study of Autopsy Cases.Brugada syndrome with elevated cardiac biomarkers.Variants in the SCN5A Promoter Associated With Various Arrhythmia PhenotypesUtilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.Dependence of phase-2 reentry and repolarization dispersion on epicardial and transmural ionic heterogeneity: a simulation study.A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death.Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic AdvancesAnaesthetic Management in Brugada Syndrome - A Case Report.SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patientsSudden cardiac death in young athletes: preparticipation screening for underlying cardiovascular abnormalities and approaches to prevention.Genetic etiology and evaluation of sudden cardiac death.Drug-induced Brugada syndrome by noncardiac agents.Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.Negative autopsy and sudden cardiac death.Brugada syndrome: clinical and genetic findings.An update on risk factors for drug-induced arrhythmias.Computational rabbit models to investigate the initiation, perpetuation, and termination of ventricular arrhythmia.Sudden cardiac arrest as a presentation of Brugada syndrome unmasked by thyroid storm.Medico-legal perspectives on sudden cardiac death in young athletes.Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome.A case of Brugada Syndrome unmasked by a postoperative febrile state.Rare Association of two Genetic Causes of Sudden Death in a Young Survivor.
P2860
Q27328980-8D32E2D0-3084-46A4-85D7-EA22FAC562C0Q28074918-F7C40E6F-C0AA-4AFA-A7DD-E0C82B8290ABQ28553287-C31EFE14-2F8A-4F96-9F53-90F2D505D8BAQ33162743-A0AC7046-6E06-46FB-9129-C9F94393B86AQ33163163-407AA83F-89A8-4F7F-B182-024E62201695Q33163627-64DD0529-4AD5-4FD3-BFFC-43F95F4A6E7FQ33164193-F68C3C87-8FB3-4B90-96AF-3BDD7F2C9E45Q33164391-698DC189-1724-49EA-9582-11AF2A95D94BQ33164900-282B2B72-3211-45DC-B6EF-2D9C3E687C1EQ33167104-03098AC7-1170-4FE8-AAEE-41D2ABE89673Q33718559-A64587D3-3B3F-4698-90DE-44812538BE49Q34671938-FDADA71E-840B-4F7A-9A1B-3D318EA85AADQ34997072-55A6D55F-C140-4630-B57D-30C61F20D3F3Q35027921-41FC4D08-941B-4F3E-8E9C-65D4112851C1Q35049529-EB54B806-78A7-4D7F-88C6-B7B9184DB9D9Q35691043-110B3076-6650-4DBF-9FA1-A1B84BA1DD36Q36371585-65A363EB-183B-4C6D-A516-48004461BAA9Q36486478-30224502-7738-48F7-97E1-A97A72D4B374Q36663914-DE716DE9-CD1D-40B1-8818-5AAF3BB4586AQ36987021-2969673B-1C46-46AE-BBDF-2FD63658B7DDQ37364440-7C27D720-4A98-44E8-A245-81381E1AE68CQ37517198-286B7726-BF99-4506-A547-7086F63CC381Q37603466-C26ECA69-1BBC-4473-ADBD-972332F58319Q37608400-0F74A93B-5D25-4101-A8A3-7AC281644747Q37728178-51E24255-D80F-4BA5-8E6B-0BD75626D60DQ37734045-68BE3E12-536B-4F92-81A6-1A7E932AED47Q37734653-1938BEA4-C80D-4449-95CD-B800CD76AA44Q38085134-DFB30847-217D-40EF-9FE8-6A9613813CF5Q38118161-DB66D2CA-CEE6-4A8E-B26D-459E47BDD9FEQ38132928-510711B1-1101-40EE-B9BC-A5B500901769Q38167806-D51EDBAC-BABF-4BB3-B3B0-179555C5B46EQ38188482-4795E6E3-0DD8-4C0A-A362-7B48B2376954Q38438088-1E1FA2CB-15A9-475C-AE39-7F3FDA10A629Q38605759-C9CA636B-9F23-42D2-9145-EDA306309C4CQ38873891-92287D07-0768-4E7B-A73D-106FA7C7C7B9Q38926030-CBE1B88D-F7BB-47B1-A76A-3CE11E04D2AEQ38961073-089D276E-480A-49F1-ACE7-E3F428C96DF6Q39949068-383C8F98-860D-4EAC-9236-DAF0830197B4Q40145476-8E0D9C48-E8F9-4821-BD97-D72CE1D6C1C8Q42317236-654DB9B4-A994-46F2-B9BD-44F0E31C5F2D
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Brugada syndrome 2012.
@ast
Brugada syndrome 2012.
@en
type
label
Brugada syndrome 2012.
@ast
Brugada syndrome 2012.
@en
prefLabel
Brugada syndrome 2012.
@ast
Brugada syndrome 2012.
@en
P356
P1433
P1476
Brugada syndrome 2012.
@en
P2093
Josep Brugada
Paola Berne
P304
P356
10.1253/CIRCJ.CJ-12-0717
P577
2012-06-13T00:00:00Z